Comprehensive COVID-19 Slideset: Special Populations and Comorbidities

Comprehensive slideset updated regularly to include the latest data and guidance on COVID prevention and treatment in special populations and patients with certain comorbidities.
Arthur Kim, MD
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Kristen Marks, MD
Renslow Sherer, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 750 KB
Released: May 18, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Related Content

Clinical Care Options (CCO) module with insights from Dr. Michael Ison on SARS-CoV-2 antivirals and monoclonal antibodies for outpatient treatment

person default Michael G. Ison, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 25, 2022 Expired: May 24, 2023

Download slides reviewing the latest data and guidance on COVID-19 vaccinations, including authorized and investigational agents, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 24, 2022

Prof Cristina Mussini discusses new data from ECCMID 2022 on COVID-19 treatments, vaccination, and long COVID, from Clinical Care Options (CCO)

Cristina Mussini, MD Released: May 23, 2022

Dr Kristen Marks on COVID-19 second booster dose: indication, which vaccine, and timing, from Clinical Care Options (CCO)

Kristen Marks, MD Released: May 20, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings